Correlating genomic features with the immune microenvironment in pediatric glioma

It is critical that we understand what immune phenotypes may be present based on immunogenomic profiling and it does not make sense to recollect and process new cases especially when limited to only one center. This will also help to decide the final panel to stain for qmIF. In review of cases from CUIMC we have identified ~10 cases with diagnostic tissue and complete clinical data for pHGG and ~60 cases with pLGG. This cohort will be used for qmIF analysis.